Avanos Medical, Inc.
AVNS
$12.43
$0.373.07%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -392.10M | 15.70M | 11.40M | -58.50M | -58.10M |
| Total Depreciation and Amortization | 45.50M | 45.90M | 34.20M | 34.40M | 35.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 412.30M | 9.80M | 6.50M | 67.50M | 64.90M |
| Change in Net Operating Assets | 35.00M | -15.90M | -19.60M | -41.30M | -38.60M |
| Cash from Operations | 100.70M | 55.50M | 61.60M | 31.20M | 32.40M |
| Capital Expenditure | -17.80M | -18.90M | -15.90M | -14.00M | -13.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -2.10M | -2.10M | -4.60M | -4.60M |
| Divestitures | 2.10M | 91.10M | 91.10M | 91.10M | 89.00M |
| Other Investing Activities | -11.80M | -9.00M | -- | -- | -- |
| Cash from Investing | -27.50M | 61.10M | 24.20M | 23.60M | 21.60M |
| Total Debt Issued | 20.00M | 20.00M | 20.00M | 20.00M | 0.00 |
| Total Debt Repaid | -53.60M | -122.90M | -109.70M | -109.70M | -119.70M |
| Issuance of Common Stock | 1.10M | 1.10M | 500.00K | 500.00K | 600.00K |
| Repurchase of Common Stock | -12.80M | -19.10M | -19.00M | -18.10M | -10.10M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.80M | -15.50M | -12.20M | -12.20M | -11.70M |
| Cash from Financing | -49.10M | -136.40M | -73.70M | -72.80M | -94.20M |
| Foreign Exchange rate Adjustments | -4.10M | 1.70M | -100.00K | -300.00K | 1.80M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.00M | -18.10M | 10.40M | -19.90M | -40.00M |